Compare Bristol-Myers Squibb Co (BMY) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Victoria's Secret & Co — how do they compare? Bristol-Myers Squibb Co trades at $58.45 (market cap $116.30B), while Victoria's Secret & Co trades at $83.04 (market cap $6.51B). The key difference: Bristol-Myers Squibb Co is far larger — about 17.9× Victoria's Secret & Co's market cap, and Bristol-Myers Squibb Co pays a 4.42% dividend while Victoria's Secret & Co pays none. Which is the better fit depends on your goals.
| BMY | VSXY | |
|---|---|---|
Market Cap | $116.30B | $6.51B |
Sector | Health | Consumer Cyclical |
52-Week High | $62.37 | $88.50 |
52-Week Low | $42.60 | $17.70 |
Enterprise Value | $152.24B | $9.16B |
Dividend Yield | 4.42% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
